Comparative analysis of calprotectin and helicobacter pylori in the faces and interleukin-6 in the blood of patients with and without COVID-19 before and after the treatment

Main Article Content

Abdigaffar Gadaev
Muazzamkhon Ismoilova
Rustam Turakulov

Abstract

Aim of the study: To examine the state of the gastrointestinal organs of patients, recovered from Covid-19 using indicators of calprotectin and Helicobacter pylori in feces and interleukin-6 in blood, as well as improvement of the treatment. Materials and methods of the study: In accordance with the aim of the study, 100 patients with gastrointestinal symptoms were observed. 42 of them (42%) were men and 58 (58%) were women. Patients were divided into 2 groups. The first group consisted of patients "relatively recovered" from Covid-19 with no detected immunoglobulin M but with gastrointestinal symptoms (27 men and 33 women; average age 55.06±2.1 years). The second, i.e. control group, consisted of patients, who did not have Covid-19 but had gastrointestinal symptoms (15 men and 25 women; average age 63.4±1.5 years). The levels of calprotectin and H. pylori in feces as well as interleukin-6 in the blood of patients involved in the study were measured.Conclusion. Although positive results were observed after the complex treatment in all groups, in all cases, where patients received rebamipide, changes were more evident. In the group receiving rebamipid a reliable decrease in inflammatory processes in the body of the patients, including the gastrointestinal system was also observed. This was shown by a decrease in calprotectin and H.pylori in their feces and interleukin-6 in their blood.


Google Scholar

CrossRef

OUCI

Scilit

WorldCat

Index Copernicus

Semantic Scholar

Article Details


How to Cite
Gadaev, A., Ismoilova, M., & Turakulov, R. (2022). Comparative analysis of calprotectin and helicobacter pylori in the faces and interleukin-6 in the blood of patients with and without COVID-19 before and after the treatment. Scientific Collection «InterConf+», (26(129), 236–242. https://doi.org/10.51582/interconf.19-20.10.2022.025
Author Biographies

Abdigaffar Gadaev, Tashkent Medical Academy

Doctor of Medical Sciences, Professor of the Department of Internal Medicine № 3

Muazzamkhon Ismoilova, Fergana Medical Institute of Public Health

Assistant of the Department of Internal Medicine

References

Chan K.H., Poon L.L., Cheng V.C., Guan Y., Hung I.F., Kong J., et al. Detection of SARS coronavirus in patients with suspected SARS. Emerg Infect Dis. 2004;10(2):294-9. DOI: https://doi.org/10.3201/eid1002.030610

Gadaev АG, Turakulov RI, et al. "Assessment of Erythropoietin Levels and Correlation with Cytokines in Patients with Chronic Heart Failure." (2021).

Gadaev A. G., Turakulov R. I., Kurbonov A. K. Occurrence of anemia in chronic heart failure and its negative impact on the course of the disease //Medical Journal of Uzbekistan.-2019-2.-S. – С. 74-77.

Ismatullaevich T. R., Gadayevich G. A. Dynamics of cytokines and level of hepsidine in patients with chronic heart failure with anemia //European science review. – 2018. – № . 3-4. – С. 193-195.

Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395(10224):565-74. DOI: https://doi.org/10.1016/S0140-6736(20)30251-8

Matysiak-Budnik T, Heyman M, Megraud F. Review article:rebamipide and the digestive epithelial barrier. Aliment Pharmacol Ther. 2003;18 (Suppl. 1):55-62. doi:10.1046/j.1365-2036.18.s1.6.x. DOI: https://doi.org/10.1046/j.1365-2036.18.s1.6.x

Pan L., Mu M., Ren H. G., Yang P., Sun Y. Wang R., et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol, 2020;115(5):766-73. DOI: https://doi.org/10.14309/ajg.0000000000000620

Tang A., Tong Z.D., Wang H.L., Dai Y.X., Li K.F., Liu J.N., et al. Detection of novel coronavirus by RT-PCR in stool specimen from asymptomatic child, China. Emerg Infect Dis. 2020;26(6):1337-39. DOI: https://doi.org/10.3201/eid2606.200301

Ungaro R.C., Sullivan T., Colombel J.-F., Patel G. What should gastroenterologists and patients know about COVID-19? Clin Gastroenterol Hepatol. 2020;18(7):1409-11. DOI: https://doi.org/10.1016/j.cgh.2020.03.020

Wu Y., Guo C., Tang L., Hong Z., Zhou J., Dong X., et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol 2020;5(5):434-35. DOI: https://doi.org/10.1016/S2468-1253(20)30083-2

Xiao F., Tang M., Zheng X. Liu Y., Li X., Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020; 158(6):1831-33. DOI: https://doi.org/10.1053/j.gastro.2020.02.055

Young B.E., Ong S.W.X., Kalimuddin S., Low J.G., Tan S.J., Loh J., et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. 2020;323(15):1488-94. DOI: https://doi.org/10.1001/jama.2020.3204

Туракулов Р. И. Влияние анемии на толерантность к физической нагрузке и качество жизни больных хронической сердечной недостаточностью //European research: innovation in science, education and technology. – 2018. – С. 133-135.